Abbvie Inc

NYSE: ABBV
$192.88
-$0.74 (-0.4%)
Real Time Data Delayed 15 Min.

ABBV Articles

The December 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The November 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
The top analyst upgrades, downgrades and initiations seen on Tuesday included AbbVie, AMAG Pharmaceuticals, Crocs, HCA, Kellogg, Kosmos Energy, Mylan, Pandora Media and Square.
AbbVie released its third quarter financial results before the markets opened on Friday. The pharma giant said that it had $2.14 in earnings per share (EPS) and $8.24 billion in revenue, compared...
Encana, Hanesbrands, Abbvie, and Annaly Capital Management all posted new 52-week lows Thursday.
The October 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
These four top pharmaceutical companies have longstanding franchises with huge sales and revenues, and their dividend-paying stocks look like outstanding choices for worried investors to consider...
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Here are 13 companies with solid dividends that currently yield more than both the 10-year Treasury note and the 30-year Treasury bond.
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
AbbVie shares took a dip on Wednesday after it was announced that the pharma giant would be facing a lawsuit from the California Department of Insurance in regards to allegedy kickbacks given to...
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.